Terns Acquired by Merck | Healthcare M&A Deal

Merck has acquired Terns, a healthcare services other business in the United States. Terns supports oncology and leukemia-focused research and development activities that can strengthen Merck’s hematology pipeline. Merck acquisitions in healthcare M&A are aimed at expanding platform capabilities for targeted cancer therapies and improving development momentum. The strategic acquisition is categorized as a platform acquisition and is currently announced, with deal size undisclosed and no public close date or advisor details provided.